Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation
暂无分享,去创建一个
T. Saleh | D. Dryer | Alastair E Cribb | J. Guernsey | M Joy Knight | Dagny Dryer | Judy Guernsey | Kimberly Hender | Marvin Tesch | Tarek M Saleh | A. Cribb | M. J. Knight | M. Tesch | K. Hender | Marvin Tesch
[1] G. Murray,et al. Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1 , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] J. Liehr,et al. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[3] G. Colditz,et al. Association of CYP1B1 polymorphisms and breast cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] H. Bradlow,et al. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Liehr,et al. Carcinogenicity of catechol estrogens in Syrian hamsters. , 1986, Journal of steroid biochemistry.
[6] P. Boyle,et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.
[7] N. Roodi,et al. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. , 1998, Cancer research.
[8] G. Vollmer,et al. Catecholestrogens are MCF-7 cell estrogen receptor agonists , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[9] H. Yamazaki,et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.
[10] N. Walker,et al. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] E. Cavalieri,et al. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. , 2001, Metabolism: clinical and experimental.
[12] A. Conney,et al. Functional role of estrogen metabolism in target cells: review and perspectives. , 1998, Carcinogenesis.
[13] C. Schneeberger,et al. Production and actions of estrogens. , 2002, The New England journal of medicine.
[14] K. Humphreys,et al. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. , 2003, Carcinogenesis.
[15] B. Zhu,et al. NADPH-dependent metabolism of 17β-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms , 2005, Steroids.
[16] M. Gerber,et al. Interactions between genetic polymorphism of cytochrome P450‐1B1, sulfotransferase 1A1, catechol‐o‐methyltransferase and tobacco exposure in breast cancer risk , 2003, International journal of cancer.
[17] B. Zumoff. Does Postmenopausal Estrogen Administration Increase the Risk of Breast Cancer? Contributions of Animal, Biochemical, and Clinical Investigative Studies to a Resolution of the Controversy , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[18] J. Lefebvre,et al. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation , 1989, Molecular and Cellular Endocrinology.
[19] A. Conney,et al. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. , 2003, Endocrinology.
[20] J. Bolton,et al. Role of quinoids in estrogen carcinogenesis. , 1998, Chemical research in toxicology.
[21] J. Fishman,et al. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Kassi,et al. The oestrogen receptor codon 10 polymorphism detected in breast cancer is also present in non-malignant cells , 1999, Journal of Cancer Research and Clinical Oncology.
[23] K. Korzekwa,et al. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. , 1997, Carcinogenesis.
[24] A. Conney,et al. Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16alpha-hydroxylation of estrone but not 17beta-estradiol. , 2003, Cancer research.
[25] J. Wittliff,et al. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. , 1989, Journal of steroid biochemistry.
[26] H. Strobel,et al. Cytochrome P-450-mediated redox cycling of estrogens. , 1986, The Journal of biological chemistry.
[27] A. V. Landeghem,et al. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. , 1985, Cancer research.
[28] J. Liehr,et al. Free radical generation by redox cycling of estrogens. , 1990, Free radical biology & medicine.
[29] Yager Jd,et al. Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .
[30] B. Ponder,et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. , 2005, Journal of the National Cancer Institute.
[31] A. Conney,et al. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. , 2001, The Journal of pharmacology and experimental therapeutics.
[32] J. Dwyer,et al. Estrogen metabolism and excretion in Oriental and Caucasian women. , 1994, Journal of the National Cancer Institute.
[33] L. Horn,et al. CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes , 2004, British Journal of Cancer.
[34] J. Sparano,et al. Urinary estrogen metabolites and breast cancer: a case-control study. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] E. Taioli,et al. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. , 1999, Cancer detection and prevention.
[36] G. Bronte,et al. Sex Steroids, Carcinogenesis, and Cancer Progression , 2004, Annals of the New York Academy of Sciences.
[37] W. Busby,et al. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[38] J. Russo,et al. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[39] M. Osborne,et al. Genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1993, Recent progress in hormone research.
[40] Y Wang,et al. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[41] F. Guengerich,et al. 16 α-Hydroxylation of estrone by human cytochrome P 4503 A 4 / 5 , 1998 .
[42] J. Yager,et al. Molecular mechanisms of estrogen carcinogenesis. , 1996, Annual review of pharmacology and toxicology.
[43] E. Cavalieri,et al. A Unifying Mechanism in the Initiation of Cancer and Other Diseases by Catechol Quinones , 2004, Annals of the New York Academy of Sciences.
[44] X. Shu,et al. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection , 2003, Steroids.
[45] F. Naftolin,et al. Kinetics of catechol estrogen-estrogen receptor dissociation: A possible factor underlying differences in catechol estrogen biological activity , 1983, Steroids.
[46] T. Shimada,et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. , 1999, Carcinogenesis.
[47] O. Pelkonen,et al. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue , 2001, Breast Cancer Research and Treatment.
[48] I. Roots,et al. Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone. , 2005, Cancer research.
[49] I. Helenowski,et al. Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[50] L. Kuller,et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. , 1998, British Journal of Cancer.
[51] A. D. Rodrigues,et al. Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. , 1999, Biochemical pharmacology.
[52] C. Martucci,et al. P450 enzymes of estrogen metabolism. , 1993, Pharmacology & therapeutics.
[53] Rodrigues Ad,et al. Integrated Cytochrome P450 Reaction Phenotyping: Attempting to Bridge the Gap Between cDNA-expressed Cytochromes P450 and Native Human Liver Microsomes , 1999 .
[54] David Bouwman,et al. Cytochrome p450 and glutathione transferase expression in human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[55] H. Yamazaki,et al. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. , 1998, Chemical research in toxicology.
[56] R. Edwards,et al. Expression of CYP3A4 in human breast tumour and non-tumour tissues. , 2003, Cancer letters.
[57] Francesmary Modugno,et al. A Potential Role for the Estrogen-metabolizing Cytochrome P450 Enzymes in Human Breast Carcinogenesis , 2003, Breast Cancer Research and Treatment.
[58] E. Taioli,et al. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. , 1995, Cancer research.
[59] A. Harris,et al. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. , 1990, Carcinogenesis.
[60] I. Helenowski,et al. Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement. , 2005, The Journal of clinical endocrinology and metabolism.
[61] J. Fishman. Aromatic hydroxylation of estrogens. , 1983, Annual review of physiology.
[62] J. Liehr. Genotoxic effects of estrogens. , 1990, Mutation research.
[63] N. Chauret,et al. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[64] F. Guengerich,et al. 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. , 1998, Carcinogenesis.
[65] J. Seegers,et al. Effects of 17β-Estradiol Metabolites on Cell Cycle Events in MCF-7 Cells , 1992 .
[66] M. Osborne,et al. 2-hydroxyestrone: the 'good' estrogen. , 1996, The Journal of endocrinology.
[67] K. Anderson,et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[68] M. Osborne,et al. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1992, Journal of the National Cancer Institute.
[69] D. Spandidos,et al. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. , 2001, International journal of molecular medicine.
[70] A. Hirvonen,et al. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. , 2003, Mutation research.